Founder Talk - What It Takes to Build a DeepTech Company in Healthcare
Founder Talk - What It Takes to Build a DeepTech Company in Healthcare
From Science Fiction to Healthcare
How do you bring deep-tech innovation from the lab to the hospital? Alexander Leutner, CEO of Cellbricks Therapeutics, shares insights into building a bioprinting company and what it takes to turn an ambitious vision into reality in one of the world’s most highly regulated industries.
Presented by
Track: World of AI & Future of Tech
Language: English
Bioprinted organ tissue sounds like science fiction – Alexander Leutner is building the company that wants to deliver it to hospitals. As CEO of Berlin-based Cellbricks Therapeutics, he is turning a light-based 3D-bioprinting platform into regenerative medicine products, driven in part by a deeply personal experience: donating a kidney to his younger brother.
Before that, he co-founded an RWTH Aachen spin-off and scaled it through to its acquisition by Hexagon. In this talk, he shares what building DeepTech in one of the world's most regulated industries really demands: long development cycles, patient capital, clinical validation, and a team willing to bet a decade on it.
From lab to hospital: What it takes to bring deep tech into clinical application.
Building in healthcare: Why long development cycles and regulatory requirements demand resilience and patience.
Patient capital: Why deep-tech innovation needs time and long-term investment.
The founder journey: Lessons from building and scaling a deep-tech company.
Driven by purpose: How personal experiences can shape an entrepreneurial vision.
Building in healthcare: Why long development cycles and regulatory requirements demand resilience and patience.
Patient capital: Why deep-tech innovation needs time and long-term investment.
The founder journey: Lessons from building and scaling a deep-tech company.
Driven by purpose: How personal experiences can shape an entrepreneurial vision.
